Researchers from the Center for Regenerative Medicine at Boston Medical Center and Boston University School of Medicine used variants of CRISPR to understand the functions of the genes that cause ...

Tokyo, Japan - Chronic obstructive pulmonary disease (COPD) causes illness and death worldwide. It is characterized by destruction of the walls of tiny air sacs in the lungs, known as emphysema, and a ...

Researchers at Weill Cornell Medicine and New York-Presbyterian in New York have discovered that injecting mice with healthy pulmonary endothelial cells (ECs)—the cells that line the walls of blood ...

Symptoms of stage 3 and 4 emphysema may significantly affect a person’s ability to perform daily activities, such as showering. People may experience frequent flare-ups, worsening shortness of breath, ...

Emphysema is a major manifestation of chronic obstructive lung disease, which affects more than 16 million Americans and is the fourth highest cause of death in the United States. This disease is ...

Chronic emphysema is a type of chronic obstructive pulmonary disease (COPD) caused by damage to the air sacs in the lungs. Although there is no cure, you can manage the disease with lifestyle changes ...

Surgical emphysema is another term for subcutaneous emphysema. It occurs when air or gas enters the subcutaneous tissue, which is the deepest layer of the skin. People can develop surgical emphysema ...

With emphysema, you can have symptoms like shortness of breath, coughing, wheezing, and chest tightness. Your symptoms can ...

NUS scientists have discovered a novel property of a protein found in human lungs that could lead to the development of biologic drugs to treat chronic obstructive pulmonary disease (COPD), a ...